...
首页> 外文期刊>Nanotechnology >Drug loading and release on tumor cells using silk fibroin-albumin nanoparticles as carriers
【24h】

Drug loading and release on tumor cells using silk fibroin-albumin nanoparticles as carriers

机译:丝素蛋白-白蛋白纳米颗粒作为载体在肿瘤细胞上的载药和释放

获取原文
获取原文并翻译 | 示例
           

摘要

Polymeric and biodegradable nanoparticles are frequently used in drug delivery systems. In this study silk fibroin-albumin blended nanoparticles were prepared using the desolvation method without any surfactant. These nanoparticles are easily internalized by the cells, reside within perinuclear spaces and act as carriers for delivery of the model drug methotrexate. Methotrexate loaded nanoparticles have better encapsulation efficiency, drug loading ability and less toxicity. The in vitro release behavior of methotrexate from the nanoparticles suggests that about 85% of the drug gets released after 12 days. The encapsulation and loading of a drug would depend on factors such as size, charge and hydrophobicity, which affect drug release. MTT assay and conjugation of particles with FITC demonstrate that the silk fibroin-albumin nanoparticles do not affect the viability and biocompatibility of cells. This blended nanoparticle, therefore, could be a promising nanocarrier for the delivery of drugs and other bioactive molecules.
机译:聚合物和可生物降解的纳米粒子经常用于药物输送系统。在这项研究中,使用去溶剂化方法在没有任何表面活性剂的情况下制备了丝素蛋白-白蛋白混合纳米粒子。这些纳米粒子很容易被细胞内化,驻留在核周空间内,并充当模型甲氨蝶呤药物递送的载体。负载甲氨蝶呤的纳米粒子具有更好的包封效率,载药能力和较低的毒性。甲氨蝶呤从纳米粒子的体外释放行为表明,约125%的药物在12天后释放。药物的封装和载量将取决于影响药物释放的因素,例如大小,电荷和疏水性。 MTT分析和FITC对粒子的缀合表明,丝素蛋白-白蛋白纳米粒子不会影响细胞的活力和生物相容性。因此,这种混合的纳米颗粒可能是用于药物和其他生物活性分子递送的有前途的纳米载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号